AMNEAL PHARMACEUTICALS INC CLASS A (AMRX) — insider trading
Health Care · NASDAQ
AMNEAL PHARMACEUTICALS INC CLASS A (AMRX) has 51 reported SEC Form 4 insider transactions in our data, including 5 open-market sales among the most recent 51 (latest 2026-09-17).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-17 | BUCHI J KEVIN | Director | Bona fide gift | 20,445 | — | $0 | Form 4 |
| 2026-09-11 | BUCHI J KEVIN | Director | Option exercise / conversion (derivative) | 20,445 | — | $0 | Form 4 |
| 2026-09-11 | BUCHI J KEVIN | Director | Option exercise / conversion | 20,445 | $14.45 | $295.4K | Form 4 |
| 2026-09-01 | BOYER ANDREW S | Officer (Executive Vice President) | Bona fide gift | 80,000 | — | $0 | Form 4 |
| 2026-08-21 | BOYER ANDREW S | Officer (Executive Vice President) | Bona fide gift | 152,426 | — | $0 | Form 4 |
| 2026-08-13 | Kiely John | Director | Bona fide gift | 10,000 | — | $0 | Form 4 |
| 2026-08-13 | Kiely John | Director | Open-market sale | 50,000 | $17.64 | $882.0K | Form 4 |
| 2026-08-12 | Daly Jason B. | Officer (EVP, Chief Legal Officer) | Open-market sale | 210,000 | $17.40 | $3.65M | Form 4 |
| 2026-08-12 | Shah Nikita | Officer (Executive Vice President) | Open-market sale | 146,403 | $17.51 | $2.56M | Form 4 |
| 2026-08-11 | BUCHI J KEVIN | Director | Option exercise / conversion | 168,573 | $17.18 | $2.90M | Form 4 |
| 2026-08-11 | Daly Jason B. | Officer (EVP, Chief Legal Officer) | Open-market sale | 6,613 | $17.70 | $117.1K | Form 4 |
| 2026-08-10 | Patel Chirag K. | Director, Officer (President & Co-CEO) | Grant / award / vesting | 6,381,734 | — | — | Form 4 |
| 2026-08-10 | Patel Gautam | Director | Grant / award / vesting | 283,632 | — | — | Form 4 |
| 2026-08-10 | Patel Chintu | Director, Officer (Co-CEO) | Grant / award / vesting | 6,381,734 | — | — | Form 4 |
| 2026-08-10 | Patel Tushar Bhikhubhai | 10% owner | Grant / award / vesting | 12,763,469 | — | — | Form 4 |
| 2026-05-11 | Autor Deborah M. | Director | Open-market sale | 34,819 | $12.94 | $450.6K | Form 4 |
| 2026-05-07 | Yanai Shlomo | Director | Option exercise / conversion (derivative) | 34,819 | — | $0 | Form 4 |
| 2026-05-07 | Yanai Shlomo | Director | Option exercise / conversion | 34,819 | — | — | Form 4 |
| 2026-05-07 | MEISTER PAUL M | Director | Option exercise / conversion (derivative) | 48,747 | — | $0 | Form 4 |
| 2026-05-07 | MEISTER PAUL M | Director | Option exercise / conversion | 48,747 | — | — | Form 4 |
| 2026-05-07 | Nark Ted C | Director | Option exercise / conversion (derivative) | 34,819 | — | $0 | Form 4 |
| 2026-05-07 | Nark Ted C | Director | Option exercise / conversion | 34,819 | — | — | Form 4 |
| 2026-05-07 | Kiely John | Director | Option exercise / conversion (derivative) | 34,819 | — | $0 | Form 4 |
| 2026-05-07 | Kiely John | Director | Option exercise / conversion | 34,819 | — | — | Form 4 |
| 2026-05-07 | Patel Gautam | Director | Option exercise / conversion (derivative) | 34,819 | — | $0 | Form 4 |
| 2026-05-07 | Patel Gautam | Director | Option exercise / conversion | 34,819 | — | — | Form 4 |
| 2026-05-07 | George Jeffrey P. | Director | Option exercise / conversion (derivative) | 34,819 | — | $0 | Form 4 |
| 2026-05-07 | George Jeffrey P. | Director | Option exercise / conversion | 34,819 | — | — | Form 4 |
| 2026-05-07 | Autor Deborah M. | Director | Option exercise / conversion (derivative) | 34,819 | — | $0 | Form 4 |
| 2026-05-07 | Autor Deborah M. | Director | Option exercise / conversion | 34,819 | — | — | Form 4 |
| 2026-05-07 | BUCHI J KEVIN | Director | Option exercise / conversion (derivative) | 34,819 | — | $0 | Form 4 |
| 2026-05-07 | BUCHI J KEVIN | Director | Option exercise / conversion | 34,819 | — | — | Form 4 |
| 2026-05-06 | Yanai Shlomo | Director | Grant / award / vesting (derivative) | 19,824 | — | $0 | Form 4 |
| 2026-05-06 | MEISTER PAUL M | Director | Grant / award / vesting (derivative) | 30,837 | — | $0 | Form 4 |
| 2026-05-06 | Nark Ted C | Director | Grant / award / vesting (derivative) | 19,824 | — | $0 | Form 4 |
| 2026-05-06 | Kiely John | Director | Grant / award / vesting (derivative) | 19,824 | — | $0 | Form 4 |
| 2026-05-06 | Patel Gautam | Director | Grant / award / vesting (derivative) | 19,824 | — | $0 | Form 4 |
| 2026-05-06 | George Jeffrey P. | Director | Grant / award / vesting (derivative) | 19,824 | — | $0 | Form 4 |
| 2026-05-06 | Autor Deborah M. | Director | Grant / award / vesting (derivative) | 19,824 | — | $0 | Form 4 |
| 2026-05-06 | BUCHI J KEVIN | Director | Grant / award / vesting (derivative) | 19,824 | — | $0 | Form 4 |
| 2026-03-04 | Patel Chintu | Director, Officer (Co-CEO) | Option exercise / conversion (derivative) | 92,593 | — | $0 | Form 4 |
| 2026-03-04 | Patel Chintu | Director, Officer (Co-CEO) | Shares withheld for taxes / exercise cost | 28,983 | $13.30 | $385.5K | Form 4 |
| 2026-03-04 | Patel Chintu | Director, Officer (Co-CEO) | Option exercise / conversion | 92,593 | — | — | Form 4 |
| 2026-03-03 | Patel Chintu | Director, Officer (Co-CEO) | Option exercise / conversion (derivative) | 733,944 | — | $0 | Form 4 |
| 2026-03-03 | Patel Chintu | Director, Officer (Co-CEO) | Option exercise / conversion (derivative) | 59,931 | — | $0 | Form 4 |
| 2026-03-03 | Patel Chintu | Director, Officer (Co-CEO) | Shares withheld for taxes / exercise cost | 315,885 | $13.31 | $4.20M | Form 4 |
| 2026-03-03 | Patel Chintu | Director, Officer (Co-CEO) | Option exercise / conversion | 733,944 | — | — | Form 4 |
| 2026-03-03 | Patel Chintu | Director, Officer (Co-CEO) | Shares withheld for taxes / exercise cost | 17,112 | $13.31 | $227.8K | Form 4 |
| 2026-03-03 | Patel Chintu | Director, Officer (Co-CEO) | Option exercise / conversion | 59,931 | — | — | Form 4 |
| 2026-03-02 | Patel Chirag K. | Director, Officer (President & Co-CEO) | Grant / award / vesting (derivative) | 544,663 | — | $0 | Form 4/A |
| 2026-03-02 | Patel Chintu | Director, Officer (Co-CEO) | Grant / award / vesting (derivative) | 544,663 | — | $0 | Form 4/A |
Ask the chat about AMRX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: AMNEAL PHARMACEUTICALS INC CLASS A (AMRX).
Last updated 2026-09-17 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.